Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
3
×
europe top stories
3
×
fda
life sciences
national blog main
national top stories
3
×
boston blog main
boston top stories
europe blog main
national
new york top stories
san francisco top stories
abbvie
alkermes
allergan
arena pharmaceuticals
billy dunn
biogen
boulder/denver blog main
boulder/denver top stories
buprenorphine
cancer
cardiovascular disease
cariprazine
colorectal cancer
detroit blog main
detroit top stories
drug prices
drug pricing
eisai
eli lilly
europe
evrysdi
felipe jain
gene therapy
genentech
indiana blog main
indiana top stories
ionis pharmaceuticals
What
drug
fda
medicine
3
×
patients
weight
alkermes
antipsychotic
approved
atrophy
benefits
cancer
caveats
commonly
daily
designed
effect
eisai
evrysdi
favor
flags
friday
gain
green
higher
home
incidence
intended
lights
liquid
lorcaserin
loss
market
marketing
muscular
new
offer
oral
panel
post
prescribed
Language
unset
Current search:
medicine
×
" national top stories "
×
" europe top stories "
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks